Related Experiment Video
Updated: May 6, 2026
08:16
Visualizing Intracellular Sialylation with Click Chemistry and Expansion Microscopy
Published on: February 7, 2025
1.2K
Chemical tools to probe cellular O-GlcNAc signalling
Adam Ostrowski1, Daan M F van Aalten
1*Division of Molecular Microbiology, College of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K.
The Biochemical Journal
|October 26, 2013
Summary
Protein O-GlcNAcylation, a key post-translational modification, is regulated by two enzymes. Inhibitors targeting these enzymes are emerging as tools to study its role in cellular signaling pathways.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Signaling
Background:
- Protein O-GlcNAcylation is a dynamic post-translational modification crucial for numerous cellular processes.
- This modification is catalyzed by two enzymes: O-GlcNAc transferase and O-GlcNAcase.
- Over 1000 proteins are O-GlcNAcylated in human cells, impacting signaling pathways.
Purpose of the Study:
- To review recent advances in the development of inhibitors for O-GlcNAc transferase and O-GlcNAcase.
- To explore the application of these inhibitors in modulating O-GlcNAc levels.
- To understand the impact of O-GlcNAc modulation on signal transduction.
Main Methods:
- Review of scientific literature on O-GlcNAcylation inhibitors.
- Analysis of studies using inhibitors on cell lines, primary cells, and animal models.
- Examination of data on the effects of inhibitors on signal transduction pathways.
Main Results:
- Development of potent and selective inhibitors for O-GlcNAc transferase and O-GlcNAcase.
- Demonstrated utility of these inhibitors in modulating O-GlcNAc levels in various biological systems.
- Insights gained into the role of O-GlcNAcylation in innate immunity, stress response, and transcription.
Conclusions:
- O-GlcNAcylation inhibitors are valuable tools for dissecting cellular signaling.
- Further research using these inhibitors will deepen our understanding of O-GlcNAcylation's biological roles.
- Targeting O-GlcNAcylation pathways holds therapeutic potential.
